Archive for the ‘Chelation’ Category

Thimerosal Cause Neurological Damage Like Autism in Rats

Monday, December 7th, 2009



Written By Lourdes Salvador of www.americanchronicle.com

Autism is a neurodevelopmental disability characterized by social withdrawal, communication deficits, and repetitive behaviors. Both genetic and environmental factors have been implicated as causes of autism, moreover a high body burden of mercury and other toxic metals from vaccinations and environmental exposures has been increasingly given more attention.
Thimerosal is mercury containing vaccine preservative added to many childhood vaccines. It is widely suspected as a cause of an increasing widespread epidemic of childhood neurodevelopmental disorders such as autism.
Now, a new study shows that administration of thimerosal leads to long lasting neurological impairment in rats, specifically by altering the neural process of handling noxious stimuli.
Analysis also shows that significant amounts of mercury from thimerosal accumulates in the rat brain and remains long term. The mercury is not readily cleared, as was previously believed. Though mercury readily leaves the blood stream, it does not leave the body. It is now recognized to accumulate in brain tissue.
Additionally, this research is supported by various prior studies which show that children with autism suffer from a weak ability to excrete mercury and that the weaker the ability, the more severe the symptoms of autism.
Now, two new research studies investigating the effects of chelation therapy on the health and behavior of children with autism spectrum disorders have discovered that children receiving chelation to reduce mercury levels had significant improvements.
It appears that mercury may produce they symptom set recognized in the autism spectrum disorders as a form of autism.


Babies Excrete Vaccine-Mercury Quicker than Originally Thought

Thursday, January 31st, 2008

Controversial Preservative Doesn’t Have Time to Build Up in Babies’ Bodies

“Though it’s reassuring to affirm that these immunizations have always been safe, our findings really have greater implications for world health.”

February’s issue of Pediatrics offers another reason to rethink blaming the spike in autism diagnoses on thimerosal, a mercury-containing preservative routinely used in several childhood vaccines until the late ‘90s.

New research from the University of Rochester suggests that infants’ bodies expel the thimerosal mercury much faster than once thought – thereby leaving little chance for a progressive building up of the toxic metal. This debunks the myth, believed by some parents and some pediatricians, that the gauntlet of thimerosal-containing shots many infants received in the 1990s – when the average number of vaccines kids received increased sharply – had put them at risk for developmental disorders.

“Thimerosal has been used for decades, but the surge in vaccinations caused fear that possible accumulations of ethyl mercury, the kind in thimerosal, might exceed safe levels – at least, when based on the stringent risk guidelines applied to its better-understood chemical cousin, methyl mercury, which is associated with eating fish,” said Michael Pichichero, M.D., professor of Microbiology/Immunology, Pediatrics and Medicine at the University of Rochester and the study’s main author.

But scientists are learning that the two mercury species actually behave quite differently. In fact, the body rids the kind found in thimerosal more that 10 times faster than it removes the kind one might encounter in a Friday night fish fry.

In the Rochester study, 216 infants from R. Gutierrez Children’s Hospital (in Buenos Aires, Argentina, where thimerosal is still routinely used in vaccines) were divided into three age groups to have their blood-mercury levels tested both before and after shots were administered at either their newborn, 2- or 6-month checkup. Researchers learned that, in all three age groups, the half-life of ethyl mercury in the blood – or, the time it takes for the body to dispose of half the mercury, and then another half, and so on – was measured to be 3.7 days. That’s a far cry from the blood half-life of methyl mercury, which is 44 days.

“Until recently, that longer half-life was assumed to be the rule for both types of mercury. Now it’s obvious that ethyl mercury’s short half-life prevents toxic build-up from occurring. It’s just gone too fast,” Pichichero said.

To illustrate, researchers cite that infants in the 6-month-old group – who, in their lifetimes, had encountered more total ethyl mercury that any other group studied – still had the same pre-vaccination blood-mercury levels before their checkups as most 2-month-olds had before theirs. This suggests that, before each round of shots, the mercury has plenty of time to be cleared.

While the study was not specifically designed to assess the toxicity of thimerosal, it does provide data helpful for assessing related risk — in light of the short blood half-life of ethyl mercury. Moreover, the study also showed that ethyl mercury was nearly undetectable in urine samples; instead, it seemed that most of it was eliminated via stools. That’s good, because mercury in large amounts is toxic to kidneys – yet in the study sample, there was no evidence suggesting any harm to renal tissues.

These findings come in the wake of recent news from the California Department of Health, which reported last month that autism rates continue to mushroom in spite of the widespread removal of thimerosal from most U.S. childhood vaccines in 2001, though it continues to be used in vaccines used elsewhere in the world.

Thimerosal, hailed for its bacteria-killing properties, has been a vaccine staple ingredient since the 1930s. But when the Environmental Protection Agency announced in 1999 that the cumulative exposure children typically received in vaccines might exceed a safe level for intake based on methyl mercury statistics (even this “safe level” was placed ten times lower than the amount held to pose real risk), public health officials, together with the American Academy of Pediatrics, recommended its removal – though still without concrete evidence of harm. The decision demanded a new formulation be created and administered — at a higher cost.

“Though it’s reassuring to affirm that these immunizations have always been safe, our findings really have greater implications for world health,” Pichichero said. “Replacing the thimerosal in vaccines globally would put these vaccines beyond what the world community could afford for its children. It’s a relief we haven’t cause to do that.”

Pichichero has served as consultant to the World Health Organization, and his research has held considerable weight in the WHO decision to continue using thimerosal in vaccines administered in nations outside the United States.

In the past, Pichichero has also served as a consultant to vaccine manufacturers including GSK Biologicals, sanofi pasteur, Wyeth Pharmaceuticals and MedImmune.

This research was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. It was performed in conjunction with investigators Angela Gentile, M.D, Norberto Giglio, M.D., and Veronica Umido, M.D., of R. Gutierrez Children’s Hospital in Buenos Aires; Carlos Gotelli, Ph.D., and Mariano Gotelli, Ph.D., of the Center of Toxicology Research in Buenos Aires; Lihan Yan, M.S., of EMMES Corp in Rockville, Maryland; and Thomas Clarkson, Ph.D., Elsa Cernichiari, M.S., Grazyna Zareba, Ph.D., and John Treanor, M.D., of the University of Rochester.
For more media inquiries, contact:
Becky Jones
(585) 275-8490
rebecca_jones@urmc.rochester.edu

direct link to story – http://www.urmc.rochester.edu/pr/news/story.cfm?id=1848

Alternative Treatments to Autism : Chelation

Friday, April 27th, 2007
 
 

By LIDIA WASOWICZ
UPI Senior Science Writer
SAN FRANCISCO, April 27 (UPI) — An estimated one in three families with autistic children opt for alternate treatments, usually as an accompaniment to structured counseling programs, U.S. doctors report.Some parents put their children on special diets, most often eliminating gluten and casein in the belief these proteins, found respectively in flour and milk, may trigger an allergic reaction that causes or exacerbates autism.

Some take the opposite tack, loading the child up on vitamins like magnesium and B6 or on food supplements, based on the supposition a deficit in these compounds may contribute to autism and on anecdotal reports the regimes at times can ease symptoms of the neurodevelopmental disorder.

The reported results from such remedies have been mixed. Some children may improve, some worsen and still others show little or no effect.

In general, none of these strategies has strong scientific backing as a safe and effective way to address the core symptoms of autism: social isolation, repetitive behaviors and language deficits.

What is testing well with a growing number of parents and some doctors is chelation — arguably the most defended, and defamed, of the alternative options.

For half a century, chelation has been a standard, government-sanctioned remedy for heavy-metal poisoning, typically employed following an industrial accident or environmental exposure.

In recent years, the technique has been gaining favor for an unapproved and highly controversial use: as a mercury-expelling treatment for autism.

Such use ensues from the contested assumption that mercury is the problem, hence, getting it out is a big part of the solution.

“The symptoms of early infant mercury poisoning and autism are virtually identical,” said toxicologist Boyd Haley, professor of chemistry at the University of Kentucky in Lexington.

He backs the theory — dismissed by most mainstream scientists — that connects autism to the mercury-based preservative thimerosal, which until the turn of the millennium was widely used in childhood vaccines.

“Furthermore, research indicates that autistic children genetically have a harder time excreting mercury from their bodies.” Boyd said. “This is why chelation has become such a powerful key for unlocking and undoing the disorders associated with autism.”

The medical mainstream has been unwaveringly critical of the use of the technique in autistic children, deeming it ineffective at best and dangerous, even potentially deadly, at worst.

Derived from the Greek “chele,” or claw, chelation therapy uses pincer-like molecules to grasp and purge copper, iron, arsenic and other heavy metals from the bloodstream, flushing them from the body, usually through urine or feces.

The detoxifying drugs used to remove the poisons are administered through pills, creams, skin patches, rectal suppositories or intravenous infusions. Many medications can serve the purpose, including the chemical compound DMSA, which carries the FDA seal of approval as a treatment for lead poisoning.

Doctors who prescribe it for autism are doing so “off-label,” a common practice for most medications used in children. Once a drug gets the FDA nod as a specific treatment, it can be put to any other use at the physician’s discretion, and patient’s ability to pay.

Such use is not covered by insurance, which, in the case of chelation, may mean out-of-pocket expenses of thousands of dollars.

The annual cost to treat a child biomedically runs between $2,500 and $5,000, said Charlie Hoover of West Palm Beach, Fla., a founding parent of the non-profit advocacy group Generation Rescue.

He credits chelation with his young son Lenny’s recovery. In one of the often-cited anecdotes of the treatment’s success, the boy’s classic symptoms of spinning, repetitive behaviors and tantrums are said to have melted away after the metal purging.

Convinced of its therapeutic powers, more than 150 parents of autistic children concurrently launched Generation Rescue and its ad campaign May 24, 2005, with the express purpose of spreading the word about “a safe and proven detoxification treatment known as chelation therapy.”

“Our message for parents is very simple: Autism is reversible,” J.B. Handley of Lafayette, Calif., one of Generation Rescue’s founding parents whose son was diagnosed with autism, told reporters during a news conference called to announce both events. “I see every day with my own eyes how my son Jamie is recovering from what was previously perceived as an untreatable disorder.”

Many parents and, for that matter some practitioners outside the mainstream treatment community, proclaim the same message. Hundreds of doctors list their names on Web sites endorsing chelation as a remedy for autism.

“For years we have heard the experts say that autism is a lifelong disability. This simply is not true anymore, thanks to effective biomedical treatments that can restore many, if not a majority, of autistic children to full recovery,” Bernard Rimland, who died Nov. 21, 2006, told the 2005 news conference.

The famous psychologist’s landmark book, “Infantile Autism: The Syndrome and Its Implication for a Neural Theory of Behavior,” published in 1964, is credited with dismantling the notion of autism as a fallout of cold-hearted parenting that was widely held in the 1950s and 1960s.

Although it cannot work alone and should be supplemented with other treatments, chelation makes it possible to break a child out of his isolated world, its advocates say.

(Note: In this multi-part installment, based on dozens of reports, conferences and interviews, Ped Med is keeping an eye on autism, taking a backward glance at its history and surrounding controversies, facing facts revealed by research and looking forward to treatment enhancements and expansions. Wasowicz is the author of the new book, “Suffer the Child: How the Healthcare System Is Failing Our Future,” published by Capital Books.)